The Bio Report

Targeting a Natural Repair System to Restore Brain Health

02.28.2024 - By Levine Media GroupPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Rachel Lenington, chief operating officer of Athira Pharma, discusses the case for targeting the HGF/MET neurotrophic system in neurodegenerative diseases, how its experimental therapy fosgonimeton works, and why its continuing to pursue the therapy despite earlier failures.

More episodes from The Bio Report